Remove 2003 Remove Disease Remove Drugs Remove Packaging
article thumbnail

The Economics of Investigational Device Exemption (IDE) Studies: What You Need to Know About Medicare Coverage

The Premier Consulting Blog

3] Understanding Medicare Coverage for IDE Studies The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) allows for Medicare coverage of the routine costs of care provided to Medicare beneficiaries in certain categories of Investigational Device Exemption (IDE) studies. [4] 5] US Food and Drug Administration.

article thumbnail

CHMP positive opinion recommending approval of Benlysta for adult patients with active lupus nephritis

The Pharma Data

This CHMP opinion follows the recent label expansion by the US Food and Drug Administration to include LN. It causes inflammation in the kidneys and can lead to end-stage kidney disease which may require dialysis or a transplant. 2] LN can lead to end-stage kidney disease, which requires kidney dialysis or a transplant.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Agency IQ

When the document was taken back to the drawing board again in 2003, it remained on hold for more than a decade until a final version was agreed upon in 2012, with the FDA officially adopting it in 2014. While the SRP could be used to submit information on drugs and biological products, the only exception was for vaccines.

FDA 40
article thumbnail

Article EMA Thank You The devil is in the details: a deep dive into the state of Notified Body designations

Agency IQ

The directives also had special scopes describing, for example, devices incorporating drugs, IVDs and medical devices in sterile condition, etc. There are two codes that all 49 Notified Bodies received designation to – devices with a measuring function (MDS 1010) and devices that require packaging/labeling (MDT 2011).

article thumbnail

Analysis Chemical Thank You Highlights of the EPA’s Unified Agenda for Spring 2023

Agency IQ

The Iron and Steel Manufacturing Facilities NESHAP was promulgated pursuant to section 112(d) of the Clean Air Act (CAA) on May 20, 2003, and subsequently amended on July 13, 2006. See Asbestos Disease Awareness Organization v. This action will address Louisiana Environmental Action Network v. 19-CV-00871; State of California et al.

article thumbnail

A Texas Mess

Drug & Device Law

2003); Birdsong v. Under the Act a “qualified countermeasure” includes any “biological product” (what vaccines are) used “to diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease).” See Henry Schein, Inc. Stromboe , 102 S.W.3d 3d 675, 698 (Tex. Ogle , 108 S.W.3d

Vaccine 59